Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C

被引:1
|
作者
Soza, A [1 ]
Hoofnagle, JH [1 ]
机构
[1] NIDDKD, Liver Dis Sect, Digest Dis Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1053/jhep.2003.50213
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:267 / 267
页数:1
相关论文
共 50 条
  • [1] Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C
    Willson, RA
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (01) : 89 - 92
  • [2] Risk factors of anemia during interferon alfa-ribavirin combination therapy in chronic hepatitis C patients
    Akbar, F. N.
    Albar, Z.
    Lesmana, L. A.
    Akbar, N.
    PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER, 2006, : 33 - +
  • [3] Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
    Soza, A
    Everhart, JE
    Ghany, MG
    Doo, E
    Heller, T
    Promrat, K
    Park, Y
    Liang, TJ
    Hoofnagle, JH
    HEPATOLOGY, 2002, 36 (05) : 1273 - 1279
  • [4] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
  • [5] Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alfa interferon.
    Herrera, J
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [6] The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C
    Chemello, L
    Cavalletto, L
    Bernardinello, E
    Guido, M
    Pontisso, P
    Alberti, A
    JOURNAL OF HEPATOLOGY, 1995, 23 : 8 - 12
  • [7] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [8] Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C
    Bräu, N
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (03) : 191 - 197
  • [9] Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin
    Hoofnagle, JH
    Ghany, MG
    Kleiner, DE
    Doo, E
    Heller, T
    Promrat, K
    Ong, J
    Khokhar, F
    Soza, A
    Herion, D
    Park, Y
    Everhart, JE
    Liang, TJ
    HEPATOLOGY, 2003, 38 (01) : 66 - 74
  • [10] Interferon-ribavirin combination therapy for chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Chemello, L
    Alberti, A
    Bellobuono, A
    Ideo, G
    Schwartz, R
    Weiland, O
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : S131 - S134